Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients

Recruiting N/A Interventional Study
Chronic Kidney Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
400 (estimated)
Sponsor
University Hospital, Montpellier · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient who has signed the written consent form * Patient with chronic renal failure starting dialysis therapy Exclusion Criteria: * Pregnancy * Patient with chronic renal failure not yet on dialysis therapy
Contacts

Jean-Paul Cristol, Prof

+33(0)4 67 33 83 15

jp-cristol@chu-montpellier.fr

CONTACT

Marion Morena, PhD

+33(0)4 11 75 98 93

m-morenacarrere@chu-montpellier.fr

CONTACT